Evidence map›Paper›PMID 22033337›Full record

ArticleCell cycle (Georgetown, Tex.)2011

Acetylation is indispensable for p53 antiviral activity.

Cesar Muñoz-Fontela, Dolores González, Laura Marcos-Villar, Michela Campagna, Pedro Gallego, José González-Santamaría, Daniel Herranz, Wei Gu, Manuel Serrano, Stuart A Aaronson and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Histone modifiers at the crossroads of oncolytic and oncogenic viruses.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Cesar Muñoz-FontelaDepartment of Oncological Sciences, Mount Sinai School of Medicine, New York, NY, USA.
Dolores González
Laura Marcos-Villar
Michela Campagna
Pedro Gallego
José González-Santamaría
Daniel Herranz
Wei Gu
Manuel Serrano
Stuart A Aaronson
Carmen Rivas
Universidad Autónoma de Madrid · ESIcahn School of Medicine at Mount Sinai · USColumbia University · USSpanish National Cancer Research Centre · ES

Funding

PW1--A mediator of cell survival by NFKB and cell death by p53P01CA080058 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI AARONSON, STUART A · 2000 to 2016
$20.2M
Regulation of p53 acetylation and deacetylation in tumorigenesis.R01CA085533 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GU, WEI · 2000 to 2021
$5.2M
Role of Mammalian Sir2a in Apoptosis &Cell SenescenceR01CA098821 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GU, WEI · 2003 to 2012
$2.8M
NCI NIH HHS P01 CA080058NCI NIH HHS R01 CA085533NCI NIH HHS R01 CA098821
6 · The paper itself

Abstract

Tumor suppressor p53 is known to be a direct transcriptional target of type I interferons (IFNs), contributing to virus-induced apoptosis, and in turn activating itself the interferon pathway. Acetylation, among many other post-translational modifications of p53, is thought to exert a crucial role regulating p53 activity. Here, we examined the contribution of this modification on the antiviral activity mediated by p53. Our results show that virus infection induces p53 acetylation at lysine 379, and that this modification is absolutely required for p53-dependent transcriptional transactivation of both, pro-apoptotic and IFN-stimulated genes induced by virus infection, and for p53-mediated control of virus replication. Thus, our study identifies p53 acetylation as an indispensable event that enables the p53-mediated antiviral response.

Indexed as

AcetylationAnimalsAntiviral AgentsApoptosisGene Expression RegulationHerpesvirus 1, HumanInterferon Type ILysineMiceTranscriptional ActivationTumor Suppressor Protein p53VesiculovirusVirus ReplicationAntiviral AgentsInterferon Type ILysineTumor Suppressor Protein p53

Identifiers

PMID22033337
PMCPMC3685621
OpenAlexW2047591178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.